Biofil Chemicals & Pharmaceuticals Ltd.
NSE: BIOFILCHEM | BSE: 524396
₹35.62
₹-1.30
(-3.52%)
As on 27-May-2026IST
Market cap
₹59 Cr
Revenue (TTM)
₹29 Cr
P/E Ratio
21.3
P/B Ratio
2.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹3 Cr
-
ROE
3 %
-
ROCE
4.1 %
-
Industry P/E
46.86
-
EV/EBITDA
16.6
-
Debt to Equity
0
-
Book Value
₹13.1
-
EPS
₹1.7
-
Face value
10
-
Shares outstanding
16,273,800
10 Years Aggregate
CFO
₹4.71 Cr
EBITDA
₹13.04 Cr
Net Profit
₹8.50 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Biofil Chemicals
| 6.1 | 7.2 | 13.3 | -24.0 | -6.6 | -12.9 | -- |
|
BSE Healthcare
| 9.3 | 8.8 | 6.8 | 11.3 | 26.4 | 14.0 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Biofil Chemicals
| -44.5 | 6.4 | -1.9 | -11.5 | -65.9 | 789.3 | 196.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Biofil Chemicals
|
35.6 | 59.0 | 29.2 | 2.8 | 0.1 | 13.8 | 21.3 | 2.8 |
| 3,000.6 | 24,577.7 | 1,339.4 | 356.4 | 33.2 | 23.2 | 69 | 14.9 | |
| 428.8 | 16,406.4 | 2,268.6 | 150.1 | 10.6 | 5.4 | 91.5 | 4.2 | |
| 782.6 | 19,421.1 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.6 | 3.8 | |
| 991.8 | 15,788.7 | 8,279.6 | 397.8 | 9.9 | 6.4 | 39.6 | 2.2 | |
| 1,175.8 | 21,056.2 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 13.5 | 2.4 | |
| 1,791.1 | 20,554.3 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.5 | |
| 174.2 | 23,155.5 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 460.4 | 18,574.8 | 3,738.7 | 316.7 | 12.5 | 7.5 | 58.7 | 3.8 | |
| 1,771.0 | 28,787.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 135.2 | 5.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Biofil Chemicals
Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium... chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and packaging solutions. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Pharmaceuticals Limited was incorporated in 1985 and is based in Indore, India. Read more
-
Incorporated
1985
-
Chairman
Ketan Shah
-
Managing Director
Ketan Shah
-
Headquarters
Indore, Madhya Pradesh
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Biofil Chemicals
What is the current share price of Biofil Chemicals & Pharmaceuticals Ltd Today?
The share price of Biofil Chemicals & Pharmaceuticals Ltd is ₹35.62 (NSE) and ₹36.25 (BSE) as of 27-May-2026 IST. Biofil Chemicals & Pharmaceuticals Ltd has given a return of -6.55% in the last 3 years.
What is the current PB & PE ratio of Biofil Chemicals & Pharmaceuticals Ltd?
The P/E ratio of Biofil Chemicals & Pharmaceuticals Ltd is 21.28 times as on 27-May-2026, a 55 discount to its peers’ median range of 46.86 times.
The P/B ratio of Biofil Chemicals & Pharmaceuticals Ltd is 2.76 times as on 27-May-2026, a 28 discount to its peers’ median range of 3.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
120.02
|
3.56
|
|
2024
|
138.50
|
5.40
|
|
2023
|
120.33
|
3.90
|
|
2022
|
134.67
|
5.59
|
|
2021
|
86.06
|
6.62
|
What is the 52 Week High and Low of Biofil Chemicals & Pharmaceuticals Ltd?
The 52-week high and low of Biofil Chemicals & Pharmaceuticals Ltd are Rs 57.19 and Rs 25.60 as of 28-May-2026.
What is the market cap of Biofil Chemicals & Pharmaceuticals Ltd?
Biofil Chemicals & Pharmaceuticals Ltd has a market capitalisation of ₹ 59 Cr as on 27-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Biofil Chemicals & Pharmaceuticals Ltd?
Before investing in Biofil Chemicals & Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.